The Nifty has been hovering in a narrow range as investors hunt for affordable entry points, especially in the small‑cap arena where valuation gaps often present hidden upside. In this backdrop, seasoned market strategist Sumeet Bagadia has highlighted three stocks trading below ₹100 that he believes merit a buy, citing both fundamental strength and technical support. Bagadia’s shortlist includes Equitas Small Finance Bank, Meghmani Organics and Filatex India. Equitas Small, a regional lender, is praised for its expanding loan book and improving asset quality, while still trading at a discount to peers.
Meghmani Organics, a chemical manufacturer, stands out for its diversified product mix and recent capacity expansions that could benefit from lower input costs. Filatex, a textile‑processing firm, is positioned to gain from a rebound in domestic garment demand and potential export incentives. All three are priced under ₹100, offering a low‑cost exposure to sectors that could outperform if the broader market regains momentum. Bagadia advises investors to set disciplined stop‑losses—₹85 for Equitas Small, ₹70 for Meghmani Organics and ₹90 for Filatex—to cap downside risk, while targeting ₹115, ₹95 and ₹130 respectively.
He cautions that these levels assume a stable macro environment and no major policy shock. For retail portfolios, the picks can serve as tactical additions alongside core holdings, provided they fit within a diversified risk framework. Overall, the recommendation underscores a broader theme: in a market where large‑cap valuations appear stretched, selectively buying well‑priced small‑caps with clear risk parameters can enhance returns without overexposing investors to volatility.